Q&A with Avacta's CEO Alastair Smith
Episode 1315, Apr 05, 2023, 03:58 PM
(Watch the video interview HERE)
It’s currently a very busy & successful time for Avacta – a leading life sciences firm developing innovative, new cancer treatments & powerful diagnostics.
Hence, we was delighted today to catchup with CEO Alastair Smith, who took us through:
00:00 Progress of AVA6000 clinical trial wrt safety, dosing regimes, efficacy and ultimate usage.
10:25 Update on #AVCT’s preCISION enabled proteasome inhibitor AVA3996
It’s currently a very busy & successful time for Avacta – a leading life sciences firm developing innovative, new cancer treatments & powerful diagnostics.
Hence, we was delighted today to catchup with CEO Alastair Smith, who took us through:
00:00 Progress of AVA6000 clinical trial wrt safety, dosing regimes, efficacy and ultimate usage.
10:25 Update on #AVCT’s preCISION enabled proteasome inhibitor AVA3996